Watson Pharmaceuticals Inc.
311 Bonnie Circle
Corona,
CA 92880-2882
United States - Map
Phone: 951-493-5300
Web Site: http://www.watson.com
| Watson Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States. The companys products are used in various therapeutic areas, including central nervous system, hormones and synthetic substitutes, cardiovascular, nephrology, gastrointestinal, and other areas. It operates in three segments: Generic, Brand, and Distribution. The Generic segment manufactures and sells generic products for various therapeutic classes comprising anti-depressant, anti-hypertensive, anti-diabetic, antiemetic, anti-hypertensive, analgesic, oral contraceptives, analgesic, and gastrointestinal areas, as well as for osteoporosis preparation and aid to smoking cessation. The Brand segment principally offers products for male hormone replacement, hematinic, overactive bladder, and prostate cancer therapeutics, as well as specialty products for urology and nephrology products for the treatment of iron deficiency anemia. The Distribution segment distributes generic and brand pharmaceutical products to independent pharmacies; alternate care providers, such as hospitals, nursing homes, and mail order pharmacies; pharmacy chains; physicians offices; and members of buying groups. The company markets its products primarily to drug wholesalers; retailers and distributors, including national retail drug and food store chains; hospitals; clinics; mail order; and government agencies and managed healthcare providers, such as health maintenance organizations and other institutions. As of December 31, 2008, Watson Pharmaceuticals marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families, as well as distributed approximately 8,000 stock-keeping units. The company was founded in 1983 and is based in Corona, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Paul M. Bisaro , 48
Chief Exec. Officer, Pres |
$
2.00M | N/A | Mr. Edward F. Heimers Jr., 62
Exec. VP and Pres of Watsons Brand Division |
$
680.00K | N/A | Mr. David A. Buchen , 44
Sr. VP, Sec. and Gen. Counsel |
N/A
| N/A | Mr. Thomas R. Russillo , 65
Exec. VP of Global Generics and Head of Global Generics Commercial Function |
$
1.22M | N/A | Mr. R. Todd Joyce ,
Chief Financial Officer, Principal Accounting Officer, Sr. VP, Treasurer and Corp. Controller |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
Profile
